DUBLIN, Nov. 15, 2018 /PRNewswire/ --
The "Global Sepsis Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The Global Sepsis Therapeutics Market is forecast to grow at a CAGR of 5.41% during the period 2019-2023.
One trend affecting this market is the strategic alliances. There are several pharmaceutical companies working together for the development of medications for the treatment of sepsis. These alliances will increase the research toward the development of new drugs for the management of sepsis.
According to the report, one driver influencing this market is the high prevalence of sepsis. The rising prevalence of sepsis is expected to fuel the growth of the global sepsis therapeutics market.
Further, the report states that one challenge affecting this market is the product withdrawals. The global sepsis therapeutics market has an acute lack of approved therapies, resulting in huge unmet needs among sepsis patients and hampering the growth of the market.
Key Vendors
- Akorn
- Baxter
- Fresenius
- Novartis
- Pfizer
Topics Covered
1. Executive Summary
2. Scope of the Report
3. Market Landscape
4. Market Sizing
5. Five Forces Analysis
6. Customer Landscape
7. Market Segmentation by Product
8. Geographic Landscape
9. Decision Framework
10. Drivers and Challenges
11. Market Trends
12. Vendor Landscape
13. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/zmnqx2/sepsis?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article